Development of a Benchtop Laboratory Platform for Amplicon Deep Sequencing
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Centers for Disease Control and Prevention
- Recipient company
- TRACE-ABILITY INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- S11KA2DGF4J6
- Solicitation number
- Not reported
- Topic code
- ODCDC
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.
- Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
- Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
- Rapid pre-release sterility test for PET Drugs.
- Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Community Based Worksite Wellness App Linking Employees to Wellness Resources Zenji
- Nitric Oxide Releasing Ultra Slippery Antibacterial Surfaces for Indewelling Catheter Applications
- Developing a Point of CarePOCLateral Flow AssayLFAto Detect Taenia Solium
- Fluorescent Qdot Immunochromatographic Test Strips for Influenza A B and Group A Strep
- Development of a Benchtop Laboratory Platform for Amplicon Deep Sequencing
Research funding history
14 SBIR/STTR records share this UEI (2015–2024). Reported award amounts total $13,965,661. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, National Science Foundation